InvestorsHub Logo
Followers 4
Posts 855
Boards Moderated 0
Alias Born 03/06/2014

Re: None

Sunday, 02/07/2021 11:37:57 AM

Sunday, February 07, 2021 11:37:57 AM

Post# of 1706
Key take-aways from the article/video - Buyer Beware: THC Breathalyzer Won’t Save Cannabix’s Stock

https://moneyandmarkets.com/cannabix-stock-thc-breathalyzer/

Most of the investing community doesn't even know Lifeloc is a publicly traded company also working on the worlds first cannabis/marijuana breathalyzer as evidenced by the question - "I couldn’t find any other publicly-traded company that makes a THC breathalyzer, and with more states legalizing for recreational use, think this might be a good long-term option?"

Most are also not aware that Lifeloc was granted a drug detection patent similar to Cannabix's patent which caused it to trade 600% higher.

"Cannabix doesn’t have any cash flow because it hasn’t really sold anything yet." This is certainly not the case with Lifeloc. LCTC has had annual revenues between $7-$10 for many years.

Matt Clark is not aware of Lifeloc, it's revenue, patents, breathalyzer business, etc. This is his job - to profile various public companies and provide investors with advice and opinions.

Feedback@moneyandmarkets.com is his email and it would be great if a couple of us could email him and see if he would be willing to do a profile video similar to the one he just made on Cannabix. Explain to him that Cannabix is not the only publicly traded company working on a marijuana breathalyzer and do your best to point out that they are in a better position than Cannabix for manufacturing, sales, distributuion, etc. and yet they are worth over 20 times less.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LCTC News